Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has commenced manufacturing Panadol 500mg tablets at its Jamshoro facility, marking a shift towards in-house production of the popular pain relief medicine.